The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
1 other identifier
observational
39
1 country
1
Brief Summary
The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2014
CompletedFirst Posted
Study publicly available on registry
December 24, 2014
CompletedStudy Start
First participant enrolled
January 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2023
CompletedJanuary 11, 2023
March 1, 2022
8 years
December 16, 2014
January 9, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Pain Assessment
Visual Analog Scale (VAS)
Pre-operative up to 2 years post surgery
Change in Functional Assessment
Short Form 36 (SF-36)
Pre-operative up to 2 years post surgery
Change in Functional Assessment
Foot and Ankle Ability Measure (FAAM)
Pre-operative up to 2 years post surgery
Fusion, as measured by radiograph and CT scan
radiographs taken Pre-operatively, 2 weeks, 4 weeks, 6 weeks, 3 Months, 6 Months, 12 Months and 24 Months. A CT scan will be done standard of care at 6 months.
Pre-operative up to 2 years post surgery
Study Arms (1)
Tibiotalocalcaneal arthrodesis with DynaNail
Procedure/Surgery: Tibiotalocalcaneal arthrodesis with a novel dynamic compression intramedullary nail
Interventions
Tibiotalocalcaneal (TTC) arthrodesis with a novel dynamic compression intramedullary nail. The assignment of the device is at the discretion of the standard of care provider, not the study investigator.
Eligibility Criteria
Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon or his physician assistant based on clinical exam and radiographic findings. Inclusion criteria include anyone over age 18 who has ankle and subtalar arthritis and has failed nonoperative management. Typically, these patients have multiple medical comorbidities and therefore the only exclusion criteria will be patients who are not healthy enough to undergo surgery. Patients of all racial, religious, and cultural backgrounds will be included in this study. Approximately 30 patients will be recruited for the study.
You may qualify if:
- Over the age of 18
- Ankle and Subtalar arthritis
- Failed non-operative management
You may not qualify if:
- Patients who do not meet the minimum age of 18 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- MedShape, Inccollaborator
Study Sites (1)
Duke University Health System
Durham, North Carolina, 27710, United States
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Easley, MD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2014
First Posted
December 24, 2014
Study Start
January 28, 2015
Primary Completion
January 9, 2023
Study Completion
January 9, 2023
Last Updated
January 11, 2023
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share